7-nitroindazole has been researched along with Dyskinesia, Drug-Induced in 11 studies
7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic L-DOPA pharmacotherapy in Parkinson's disease is often accompanied by the development of abnormal and excessive movements known as L-DOPA-induced dyskinesia." | 1.35 | Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. ( Del-Bel, EA; Echeverry, MB; Padovan-Neto, FE; Tumas, V, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Herrero, MT | 1 |
| Yuste, JE | 1 |
| Cuenca-Bermejo, L | 1 |
| Almela, P | 1 |
| Arenas-Betancur, L | 1 |
| De Pablos, V | 1 |
| Gonzalez-Cuello, A | 1 |
| Del Bel, E | 3 |
| Navarro-Zaragoza, J | 1 |
| Fernández-Villalba, E | 1 |
| Padovan-Neto, FE | 6 |
| Ferreira, NR | 1 |
| de Oliveira-Tavares, D | 1 |
| de Aguiar, D | 1 |
| da Silva, CA | 1 |
| Raisman-Vozari, R | 3 |
| Del-Bel, E | 3 |
| Szawka, RE | 1 |
| da-Silva, CA | 4 |
| Anselmo-Franci, J | 2 |
| Romano-Dutra, AC | 1 |
| Guimaraes, FS | 1 |
| Cavalcanti-Kiwiatkoviski, R | 1 |
| Carolino, RO | 1 |
| Solís, O | 1 |
| Espadas, I | 1 |
| Del-Bel, EA | 2 |
| Moratalla, R | 1 |
| Bortolanza, M | 2 |
| Cavalcanti-Kiwiatkoski, R | 1 |
| Mitkovski, M | 1 |
| Bariotto-Dos-Santos, KD | 1 |
| Dos-Santos-Pereira, M | 1 |
| Echeverry, MB | 1 |
| Tumas, V | 2 |
| Novaretti, N | 1 |
| Del Bel, EA | 1 |
| Takuma, K | 1 |
| Tanaka, T | 1 |
| Takahashi, T | 1 |
| Hiramatsu, N | 1 |
| Ota, Y | 1 |
| Ago, Y | 1 |
| Matsuda, T | 1 |
| Araki, T | 1 |
| Mizutani, H | 1 |
| Matsubara, M | 1 |
| Imai, Y | 1 |
| Mizugaki, M | 1 |
| Itoyama, Y | 1 |
11 other studies available for 7-nitroindazole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Levodopa; Parkinson Disease; Parkinsonian D | 2023 |
Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Indazoles; Levodopa; Male; | 2013 |
Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Enzyme Inhibitor | 2014 |
Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats.
Topics: Animals; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Nitric Oxide Syntha | 2015 |
Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
Topics: Animals; Antiparkinson Agents; Benserazide; Cell Count; Corpus Striatum; Disease Models, Animal; Dop | 2015 |
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Indazoles; Inflamma | 2015 |
Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson's Disease.
Topics: Amantadine; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, | 2016 |
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; En | 2009 |
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats.
Topics: Animals; Anti-Dyskinesia Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; | 2010 |
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dopamine and cAMP-Regulated Phosphoprotein 32 | 2012 |
Nitric oxide synthase inhibitors cause motor deficits in mice.
Topics: Animals; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Enzym | 2001 |